Macrogenics reported $17.16M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Amgen AMGN:US $ 1.23B 197M
AstraZeneca AZN:LN 3.06B 1.03B
Biogen BIIB:US $ 634.9M 153M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Cerulean Pharma CERU:US $ 2.43M 190.32K
Daiichi Sankyo 4568:JP 104.74B 14.78B
Eli Lilly And LLY:US $ 1.56B 34.1M
Epizyme EPZM:US $ 27.2M 3.66M
Genmab GEN:DC 452M 60M
Geron GERN:US $ 6.7M 1.17M
Gilead Sciences GILD:US $ 1.08B 567M
Immunogen IMGN:US $ 16.65M 3.07M
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Merk MRK:US $ 2.3B 518M
Mirati Therapeutics MRTX:US $ 53.95M 10.42M
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Xencor XNCR:US $ 11.27M 102K